These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21116684)

  • 1. Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs.
    Zaheer-ul-Haq ; Khan W
    J Comput Aided Mol Des; 2011 Jan; 25(1):81-101. PubMed ID: 21116684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket.
    Höpner S; Dickhaut K; Hofstätter M; Krämer H; Rückerl D; Söderhäll JA; Gupta S; Marin-Esteban V; Kühne R; Freund C; Jung G; Falk K; Rötzschke O
    J Biol Chem; 2006 Dec; 281(50):38535-42. PubMed ID: 17005558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cyclic peptide accelerates the loading of peptide antigens in major histocompatibility complex class II molecules.
    Afridi S; Shaheen F; Roetzschke O; Shah ZA; Abbas SC; Siraj R; Makhmoor T
    Biochem Biophys Res Commun; 2015 Jan; 456(3):774-9. PubMed ID: 25522880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.
    Nielsen M; Lundegaard C; Blicher T; Peters B; Sette A; Justesen S; Buus S; Lund O
    PLoS Comput Biol; 2008 Jul; 4(7):e1000107. PubMed ID: 18604266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model.
    Knapp B; Omasits U; Bohle B; Maillere B; Ebner C; Schreiner W; Jahn-Schmid B
    Mol Immunol; 2009 May; 46(8-9):1839-44. PubMed ID: 19232439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
    Chang JW; Mechling DE; Bächinger HP; Burrows GG
    J Biol Chem; 2001 Jun; 276(26):24170-6. PubMed ID: 11319230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles.
    Dai S; Crawford F; Marrack P; Kappler JW
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11893-7. PubMed ID: 18697946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach.
    Patronov A; Dimitrov I; Flower DR; Doytchinova I
    BMC Struct Biol; 2011 Jul; 11():32. PubMed ID: 21752305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
    Kropshofer H; Bohlinger I; Max H; Kalbacher H
    Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR polymorphism affects the interaction with CD4.
    Fleury S; Thibodeau J; Croteau G; Labrecque N; Aronson HE; Cantin C; Long EO; Sékaly RP
    J Exp Med; 1995 Sep; 182(3):733-41. PubMed ID: 7650480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
    Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
    J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
    J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A roadmap for HLA-DR peptide binding specificities.
    Chelvanayagam G
    Hum Immunol; 1997 Dec; 58(2):61-9. PubMed ID: 9475335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
    Murthy VL; Stern LJ
    Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The generation of SDS-stable HLA DR dimers is independent of efficient peptide binding.
    Verreck FA; Vermeulen C; Poel AV; Jorritsma P; Amons R; Coligan JE; Drijfhout JW; Koning F
    Int Immunol; 1996 Mar; 8(3):397-404. PubMed ID: 8671626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis.
    Odunsi K; Ganesan T
    Int J Mol Med; 2001 Oct; 8(4):405-12. PubMed ID: 11562779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9.
    James EA; Moustakas AK; Bui J; Nouv R; Papadopoulos GK; Kwok WW
    J Immunol; 2009 Sep; 183(5):3249-58. PubMed ID: 19648278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice.
    Menconi F; Monti MC; Greenberg DA; Oashi T; Osman R; Davies TF; Ban Y; Jacobson EM; Concepcion ES; Li CW; Tomer Y
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14034-9. PubMed ID: 18779568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.